IDEXX Director Awarded $24.5k in Deferred Stock Units (IDXX)
IDEXX LABORATORIES INC /DE
Subscribe to track IDXX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
IDEXX Director Awarded $24.5k in Stock (IDXX)
Company: IDEXX LABORATORIES INC /DE (IDXX) Form: 4 | Filed: 2025-11-03 Significance: Low
Insider: HOOLEY JOSEPH L Title: N/A | Relationship: Director
Transaction: • Type: Grant • Shares: 39 • Price: $628.54 • Value: $24,513 • Owned After: 39
Key Insight: A routine grant of deferred stock units to a director as part of their compensation plan, representing a negligible portion of the company's market cap.
Market Context: The transaction value is insignificant compared to IDEXX's $50.36 billion market capitalization.
Comprehensive Analysis
SEC Filing Analysis: IDEXX LABORATORIES INC /DE (IDXX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine, non-discretionary award of deferred stock units as part of a compensation plan.
- Market Impact: Negligible. The transaction is too small to have any market impact.
Company Information
| Field | Value |
|---|---|
| Company | IDEXX LABORATORIES INC /DE |
| Ticker Symbol | IDXX |
| CIK | 0000874716 |
| Industry | In Vitro & In Vivo Diagnostic Substances |
Insider Information
| Field | Value |
|---|---|
| Name | HOOLEY JOSEPH L |
| CIK | 0001123847 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-30 |
| Transaction Code | A (Award) |
| Security Type | Common Stock |
| Shares Involved | 39 |
| Price Per Share | $628.54 |
| Total Value | $24,513.06 |
| Shares Owned After | 39 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $24,513.06 |
| % of Market Cap | 0.00005% |
| Shares Transacted | 39 |
| % of Shares Outstanding | 0.00005% |
| Post-Transaction Ownership | 39 shares (0.00005% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value of ~$24.5k is insignificant for a large-cap company with a market capitalization of $50.36 billion.
- Ownership Concentration: The director's holding of 39 shares is a negligible stake in the company.
- Dilution Impact: The issuance of 39 shares has no meaningful dilutive effect on the 80 million shares outstanding.
- Transaction Significance: The transaction is a routine compensation grant, not an open-market trade, and its size is far below any threshold of significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-discretionary award as part of a director's compensation plan, not an investment decision based on market sentiment. The size is immaterial.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is too small to affect trading volume.
- Sentiment Indicator: Neutral. This type of filing is routine and does not signal any particular insider sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The shares represent deferred stock units acquired under the company's Director Deferred Compensation Plan. The units vest immediately and are payable in common stock upon the director's departure from the board.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
